May 02, 2021 09:45 AM IST
Rejecting the charges of profiteering from the vaccine, Serum Institute of India CEO Adar Poonawala said that it is “totally incorrect” and added that Covishield will still be “the most affordable vaccine on the planet” even at a higher price. "
- Apr 27, 2021 01:10 PM IST
As a deadly second wave of COVID-19 continues, Nepal has also requested ventilators, oxygen cylinders and medical supplies from India. Though Nepal has approved a Chinese vaccine, it is not recognised by the WHO and there are concerns over its safety and efficacy.
- Apr 24, 2021 04:18 PM IST
"Covishield is the most affordable COVID-19 vaccine available in the market today. The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing," Serum India said in a statement.
- Apr 16, 2021 02:34 PM IST
"I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up. Your administration has the details," Poonawalla tweeted.
- Apr 07, 2021 07:19 PM IST
About 90 percent of the 86 million doses India has administered since mid-January have come from the Serum Institute of India, with the rest accounted for by a domestic vaccine developed by Bharat Biotech, which is also struggling to boost output.
- Apr 06, 2021 06:36 PM IST
Adar Poonawalla said that the Serum Institute of India has already delivered over 100 million doses to the government and is currently producing 65-70 million doses per month.
- Mar 30, 2021 10:40 PM IST
The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities minimise vaccine wastage and better plan their inoculation programmes.
- Mar 18, 2021 10:15 PM IST
The second batch of five million doses that SII is due to export to the UK will only be delivered once it is green-lighted by the Indian government.
- Mar 02, 2021 12:50 PM IST
Rivals China and India have both sold or gifted COVID-19 shots to many countries. India produces more than 60% of all vaccines sold in the world.
- Feb 03, 2021 10:50 PM IST
COVAX will be getting 240 million doses of AstraZeneca-Oxford University COVID-19 vaccine from SII and 96 million doses from AstraZeneca under the advance purchase agreement between Gavi and the vaccine makers. SII has agreed to supply COVID-19 vaccine at $3 per dose.
- Jan 21, 2021 08:30 PM IST
Maharashtra Chief Minister Uddhav Thackeray will visit Serum Institute of India's facility in Pune on January 22 to take stock of the situation.
- Jan 19, 2021 10:21 PM IST
The 100 vials at SMCH were allegedly stored at sub-zero temperature, which led to the freezing of the vaccine doses.
- Jan 18, 2021 09:13 AM IST
Serum Institute's Chief Executive Officer Adar Poonawalla said that exports of the COVID-19 vaccine doses will start only after local requirements are fully met.
- Jan 05, 2021 03:22 PM IST
"We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our COVID-19 vaccines," they said.
- Dec 22, 2020 05:22 PM IST
Pfizer was the first to apply for the EUA in India on December 5. However, it sought more time from the Subject Expert Committee (SEC) as its experts were busy and could not present their case on December 9.
- Dec 12, 2020 01:08 PM IST
“By September-October 2021 hopefully there will be enough vaccines for everyone and normal life can return,” Adar Poonawalla said.
- Dec 07, 2020 10:08 PM IST
Bharat Biotech's vaccine candidate was in the news recently after Haryana minister Anil Vij, who had volunteered for the trial and was administered a dose, had tested positive for COVID-19.
- Dec 07, 2020 05:29 PM IST
During an all-party meeting on December 4, Prime Minister Narendra Modi had said the government is forming a comprehensive vaccination strategy, and had indicated that a vaccine might be available in the coming few weeks.
- Dec 03, 2020 09:49 AM IST
Serum Institute's COVID-19 vaccine supply to private companies and in the open market will start only after orders from the government are met.
- Dec 02, 2020 10:12 PM IST
ICMR Director General Dr Balram Bhargava had on Tuesday said adverse events do occur with drugs or vaccines or any other health intervention.
- Dec 02, 2020 06:20 PM IST
Pfizer and BioNTech said on December 2 the COVID-19 vaccine will be rolled out for use from next week. Here's everything you need to know about this vaccine candidate and more
- Nov 30, 2020 05:37 PM IST
The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.
- Nov 29, 2020 08:23 PM IST
The volunteer is falsely laying the blame for his medical problems on the trial of COVID-19 vaccine Covishield, said Serum Institute of India
- Nov 28, 2020 02:40 PM IST
The participant received the vaccine on October 1 and on October 11, he started experiencing severe headaches and was not able to respond to questions, said the notice to Serum Institute of India
- Nov 26, 2020 03:41 PM IST
Despite none of the Chinese firms has released any public data on the efficacy of their shots in Phase III trials, people in the Asian countries are bending the rules to get hold of the unproven Chinese vaccines.